• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

按肥胖等级分层时,体外膜肺氧合成人患者的体重是否重要?

Does Weight Matter? Outcomes in Adult Patients on Venovenous Extracorporeal Membrane Oxygenation When Stratified by Obesity Class.

机构信息

From the Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland.

Program in Trauma, R Adams Cowley Shock Trauma Center, Baltimore, Maryland.

出版信息

Anesth Analg. 2020 Sep;131(3):754-761. doi: 10.1213/ANE.0000000000004454.

DOI:10.1213/ANE.0000000000004454
PMID:31663965
Abstract

BACKGROUND

Many believe obesity is associated with higher rates of mortality in the critically ill. The purpose of this retrospective observational study is to evaluate the association between body mass index (BMI) and survival in patients receiving venovenous (VV) extracorporeal membrane oxygenation (ECMO) for acute hypoxic or hypercarbic respiratory failure.

METHODS

All of the patients admitted to a dedicated VV ECMO unit were included. Patients <18 years of age, listed for lung transplant, or underweight were excluded. ECMO outcomes, including hospital length of stay and survival to discharge, were analyzed after stratification according to BMI. Multivariate logistic and linear regression techniques were used to assess variables associated with the outcomes of death and length of stay, respectively.

RESULTS

One hundred ninety-four patients with a median BMI of 35.7 kg/m (33-42 kg/m) were included. Obese patients were older, had higher creatinine levels, and required higher levels of positive end-expiratory pressure and mean airway pressure at time of cannulation. Survival to discharge in any group did not differ when stratified by BMI classification (P = .36). Multivariable regression did not reveal any association with greater odds of death or longer length of stay when controlling for BMI and other variables.

CONCLUSIONS

We did not detect an association between obesity and increased mortality in patients requiring VV ECMO for acute hypoxic or hypercarbic respiratory failure. These data suggest that obesity alone should not exclude candidacy for VV ECMO. Evidence for the "obesity paradox" in this population of VV ECMO patients may be supported by these data.

摘要

背景

许多人认为肥胖与危重症患者更高的死亡率有关。本回顾性观察研究的目的是评估接受静脉-静脉(VV)体外膜肺氧合(ECMO)治疗急性低氧或高碳酸呼吸衰竭患者的体重指数(BMI)与生存率之间的关系。

方法

纳入所有入住专门的 VV ECMO 病房的患者。排除年龄<18 岁、接受肺移植或体重过轻的患者。根据 BMI 分层后,分析 ECMO 结局,包括住院时间和出院生存率。使用多变量逻辑和线性回归技术分别评估与死亡和住院时间相关的变量。

结果

纳入了 194 名 BMI 中位数为 35.7 kg/m(33-42 kg/m)的患者。肥胖患者年龄更大,肌酐水平更高,在插管时需要更高的呼气末正压和平均气道压。按 BMI 分类分层时,任何组的出院生存率均无差异(P=.36)。多变量回归显示,在控制 BMI 和其他变量后,BMI 与更高的死亡几率或更长的住院时间之间没有关联。

结论

我们没有发现肥胖与接受 VV ECMO 治疗急性低氧或高碳酸呼吸衰竭的患者死亡率增加之间存在关联。这些数据表明,肥胖本身不应排除 VV ECMO 的候选资格。这些数据可能支持 VV ECMO 患者人群中“肥胖悖论”的证据。

相似文献

1
Does Weight Matter? Outcomes in Adult Patients on Venovenous Extracorporeal Membrane Oxygenation When Stratified by Obesity Class.按肥胖等级分层时,体外膜肺氧合成人患者的体重是否重要?
Anesth Analg. 2020 Sep;131(3):754-761. doi: 10.1213/ANE.0000000000004454.
2
Outcomes of Venovenous Extracorporeal Membrane Oxygenation When Stratified by Age: How Old Is Too Old?按年龄分层的静脉-静脉体外膜肺氧合治疗结果:多大年龄算太老?
ASAIO J. 2020 Aug;66(8):946-951. doi: 10.1097/MAT.0000000000001076.
3
Association Between Body Mass Index and Outcomes in Venoarterial Extracorporeal Membrane Oxygenation.体重指数与静脉-动脉体外膜肺氧合治疗结局之间的关联
Anesth Analg. 2022 Feb 1;134(2):341-347. doi: 10.1213/ANE.0000000000005689.
4
Veno-Venous Extracorporeal Membrane Oxygenation for Respiratory Failure: How Long Is Too Long?静脉-静脉体外膜肺氧合治疗呼吸衰竭:多长时间算太长?
ASAIO J. 2019 Feb;65(2):192-196. doi: 10.1097/MAT.0000000000000791.
5
Retrieval of severe acute respiratory failure patients on extracorporeal membrane oxygenation: Any impact on their outcomes?体外膜肺氧合治疗的严重急性呼吸衰竭患者的检索:对其结局有何影响?
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1621-1629.e2. doi: 10.1016/j.jtcvs.2017.10.084. Epub 2017 Nov 8.
6
Veno-Venous Extracorporeal Membrane Oxygenation (VV ECMO) for Acute Respiratory Failure Following Injury: Outcomes in a High-Volume Adult Trauma Center with a Dedicated Unit for VV ECMO.静脉-静脉体外膜肺氧合(VV ECMO)治疗创伤后急性呼吸衰竭:在一家拥有VV ECMO专用科室的大型成人创伤中心的治疗结果
World J Surg. 2018 Aug;42(8):2398-2403. doi: 10.1007/s00268-018-4480-6.
7
Developing a simple preinterventional score to predict hospital mortality in adult venovenous extracorporeal membrane oxygenation: A pilot study.开发一种简单的干预前评分以预测成人静脉-静脉体外膜肺氧合的医院死亡率:一项初步研究。
Medicine (Baltimore). 2016 Jul;95(30):e4380. doi: 10.1097/MD.0000000000004380.
8
[Predictive values of different critical scoring systems for mortality in patients with severe acute respiratory failure supported by extracorporeal membrane oxygenation].[不同危急评分系统对体外膜肺氧合支持下的严重急性呼吸衰竭患者死亡率的预测价值]
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Sep;39(9):698-703. doi: 10.3760/cma.j.issn.1001-0939.2016.09.008.
9
Venovenous Versus Venoarterial Extracorporeal Membranous Oxygenation in Inotrope Dependent Pediatric Patients With Respiratory Failure.在需要正性肌力药物治疗的伴有呼吸衰竭的儿科患者中,静脉-静脉与静脉-动脉体外膜肺氧合的比较。
ASAIO J. 2021 Apr 1;67(4):457-462. doi: 10.1097/MAT.0000000000001254.
10
The lung rescue unit-Does a dedicated intensive care unit for venovenous extracorporeal membrane oxygenation improve survival to discharge?肺抢救单元——专门用于静脉-静脉体外膜肺氧合的重症监护病房能否提高出院生存率?
J Trauma Acute Care Surg. 2017 Sep;83(3):438-442. doi: 10.1097/TA.0000000000001524.

引用本文的文献

1
Impact of obesity on outcomes of extracorporeal membrane oxygenation support: a systematic review and meta-analysis.肥胖对体外膜肺氧合支持结局的影响:系统评价和荟萃分析。
BMC Pulm Med. 2024 Mar 28;24(1):157. doi: 10.1186/s12890-024-02971-5.
2
Obesity and Extracorporeal Membrane Oxygenation.肥胖与体外膜肺氧合。
Respir Care. 2024 Mar 27;69(4):474-481. doi: 10.4187/respcare.11565.
3
Veno-venous extracorporeal membrane oxygenation in severe acute respiratory failure.静脉-静脉体外膜肺氧合用于严重急性呼吸衰竭
BJA Educ. 2024 Apr;24(4):138-144. doi: 10.1016/j.bjae.2024.01.001. Epub 2024 Feb 1.
4
A Systematic Review of Mortality Rates Among Adult Acute Respiratory Distress Syndrome Patients Undergoing Extracorporeal Membrane Oxygenation Therapy.接受体外膜肺氧合治疗的成年急性呼吸窘迫综合征患者死亡率的系统评价
Cureus. 2023 Aug 16;15(8):e43590. doi: 10.7759/cureus.43590. eCollection 2023 Aug.
5
Mortality in Patients with Obesity and Acute Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation: The Multicenter ECMObesity Study.肥胖合并急性呼吸窘迫综合征患者接受体外膜肺氧合治疗的死亡率:多中心 ECMObesity 研究。
Am J Respir Crit Care Med. 2023 Sep 15;208(6):685-694. doi: 10.1164/rccm.202212-2293OC.
6
Extracorporeal Membrane Oxygenation to Support COVID-19 Patients: A Propensity-Matched Cohort Study.体外膜肺氧合支持新型冠状病毒肺炎患者:一项倾向评分匹配队列研究
Crit Care Res Pract. 2023 Jun 12;2023:5101456. doi: 10.1155/2023/5101456. eCollection 2023.
7
The Prognostic Factors of Bloodstream Infection in Immunosuppressed Elderly Patients: A Retrospective, Single-center, Five-year Cohort Study.免疫抑制老年患者血流感染的预后因素:一项回顾性、单中心、五年队列研究。
Clin Interv Aging. 2022 Nov 18;17:1647-1656. doi: 10.2147/CIA.S386922. eCollection 2022.
8
The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox.肥胖对大容量 ECMO 中心严重 SARS-CoV-2 ARDS 结局的影响:ECMO 和皮质类固醇支持肥胖悖论。
J Crit Care. 2022 Dec;72:154162. doi: 10.1016/j.jcrc.2022.154162. Epub 2022 Oct 8.
9
Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation.影响 COVID-19 体外膜肺氧合患者生存的关键特征。
Crit Care. 2022 Jun 28;26(1):190. doi: 10.1186/s13054-022-04053-6.
10
COVID-19 outcomes of venovenous extracorporeal membrane oxygenation for acute respiratory failure vs historical cohort of non-COVID-19 viral infections.COVID-19 患者行静脉-静脉体外膜肺氧合治疗急性呼吸衰竭与非 COVID-19 病毒感染患者历史队列的结局比较。
Perfusion. 2023 Sep;38(6):1165-1173. doi: 10.1177/02676591221105603. Epub 2022 Jun 2.